がんを処置するためのクローディン１８．２に対する抗体を伴う併用療法

Title:

がんを処置するためのクローディン１８．２に対する抗体を伴う併用療法

Document Type and Number:

Japanese Patent JP6490764

Kind Code:

B2

Abstract:

The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof.

More Like This:

JP4636497	Methods and compositions for regulating and detecting WISP activity
WO/2023/140385	PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING AT LEAST ONE DISEASE SELECTED FROM GROUP CONSISTING OF INFLAMMATORY BOWEL DISEASE AND INTESTINAL TUMOR
WO/2020/185805	IMMUNE MODULATION BY BREQUINAR

Inventors:

Ughur Shaheen
Utzlem Thulec
Rita Mitt Nacht-Klaus
Stephan Dennis Jacobs
Magdalena Yadwiga Ush
Cornelia Adriana Maria Heinz
Christiane Regina Stadler

Application Number:

JP2017165303A

Publication Date:

March 27, 2019

Filing Date:

August 30, 2017

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Ganymed Pharmaceuticals Game Behr
TRON-Translationare on Corogee an der Universitate Smedizin der Johannes Gutenberg-Universitate Mainz Gemainn Nutsige Geembehr

International Classes:

A61K39/395; A61K31/282; A61K31/337; A61K31/4745; A61K31/675; A61K33/243; A61K38/20; A61P35/00

Domestic Patent References:

JP2010528075A
JP2009517354A
JP2011510632A
JP2011529172A

Foreign References:

WO2011090005A1
WO2008152822A1
WO2010141093A1

Other References:

ANTICANCER RESEARCH, 2011, Vol. 31, p. 3691-3696

Attorney, Agent or Firm:

Yasuhiko Murayama
Shinya Mitsuhiro

Previous Patent: がんを処置するためのクローディン１８．２に対する抗体を伴う併用療法

Next Patent: PRINTING CONTROL METHOD